Other
Institute for Clinical Research
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
N/A
1(20.0%)
Phase 2
1(20.0%)
Phase 1
1(20.0%)
Phase 3
1(20.0%)
Phase 4
1(20.0%)
5Total
N/A(1)
Phase 2(1)
Phase 1(1)
Phase 3(1)
+1 more
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT06610825Phase 2Recruiting
Castrate Resistant Prostate Cancer Enhertu Therapy
Role: collaborator
NCT04818320Phase 3Completed
Favipiravir in High-risk COVID-19 Patients
Role: collaborator
NCT00501956Phase 4Completed
Intradialytic Parenteral Nutrition in Hemodialysis Patients
Role: collaborator
NCT00428480Phase 1Completed
Walking Study for Stroke Rehabilitation
Role: collaborator
NCT00210301Not ApplicableUnknown
Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS
Role: lead
All 5 trials loaded